NAMSW 8-K 2026-09-29

NewAmsterdam Pharma Co N.V. (NAMSW) 8-K dated 2026-09-29 — accession 0001193125-26-406063. This URL is the filing, not the NAMSW hub.

NewAmsterdam Pharma Co N.V. (NAMSW) common stock listed on NASDAQ.

NewAmsterdam Pharma Co N.V. filed a 8-K on 2026-09-29. Accession 0001193125-26-406063.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NAMSW revenue for 2025-12-31 was $22.5M. Net income was -$203.8M. Revenue was down 50.6% from 2024-12-31 to 2025-12-31. NAMSW currently screens at market cap $0.

Not investment advice. The NAMSW SEC hub lists recent forms. The stock page is the research view.